Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia

Mette Levinsen, Diana Shabaneh, Cathrine Bohnstedt, Arja Harila-Saari, Olafur G. Jonsson, Jukka Kanerva, Anna Lindblom, Bendik Lund, Elisabeth W. Andersen, Kjeld Schmiegelow, Nordic Soc Paediat Haematology & O

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEuropean Journal of Haematology
Volume88
Issue number1
Pages (from-to)78-86
Number of pages9
ISSN0902-4441
DOIs
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Fields of Science

  • childhood acute lymphoblastic leukemia
  • treatment
  • infection
  • WHITE BLOOD-CELL
  • TRIMETHOPRIM-SULFAMETHOXAZOLE
  • PROGNOSTIC IMPORTANCE
  • DOSE INTENSITY
  • CHEMOTHERAPY
  • CHILDREN
  • RELAPSE
  • METHOTREXATE
  • RISK
  • MYELOSUPPRESSION
  • 3123 Gynaecology and paediatrics

Cite this